SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

endocrine

Thyroid Nodule Found: Should You Be Worried?

Most thyroid nodules are benign — fewer than 5% are cancerous. Finding one is not a cancer diagnosis; it is the start of a structured evaluation. Ultrasound assesses specific risk features, and a fine-needle aspiration biopsy is performed only when those features meet established thresholds.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What is a thyroid nodule?

A thyroid nodule is an abnormal growth of cells within the thyroid gland — a small butterfly-shaped gland at the base of the neck that regulates metabolism. Nodules are extremely common; high-resolution ultrasound detects them in up to 68% of adults, though the large majority are never felt or symptomatic 1. Most are solid or fluid-filled (cystic) and grow very slowly. Many are discovered incidentally during imaging done for another reason — a neck ultrasound, CT scan, or MRI.

How common are thyroid nodules, and how often are they cancerous?

Thyroid nodules are among the most common findings in adult medicine. Thyroid cancer is diagnosed in roughly 44,000 Americans per year, but the great majority of thyroid nodules are not cancer — malignancy is found in fewer than 5% of all evaluated nodules 2. When thyroid cancer does occur, the most common type — papillary thyroid carcinoma — has a 10-year survival rate exceeding 98% and is highly curable when caught before spread 2.

The clinical challenge is identifying the small subset of nodules that warrant biopsy or treatment, while avoiding unnecessary procedures for the many benign ones. Structured ultrasound risk stratification was developed specifically to solve this problem 1.

What happens after a nodule is found on ultrasound?

If a thyroid nodule is discovered, the first step is a dedicated thyroid ultrasound (if one has not already been done). The radiologist or specialist evaluates the nodule's size, composition (solid vs. cystic), echogenicity (how it appears relative to surrounding tissue), shape, margins, and whether there are suspicious calcifications 13.

Based on these features, nodules are classified into risk categories — from very low risk (e.g., a small spongiform nodule) to high suspicion (solid, hypoechoic, with irregular margins or microcalcifications). The risk category drives whether a biopsy is recommended, and at what size threshold 3.

When is a biopsy (FNA) needed?

Fine-needle aspiration (FNA) biopsy is a straightforward outpatient procedure — a very thin needle is guided by ultrasound into the nodule to collect cells for examination. It is typically recommended when 1:

  • A nodule has high or intermediate suspicion features and meets a size threshold (thresholds vary by suspicion level)
  • A nodule has been growing steadily on surveillance imaging
  • There are clinical factors that raise concern — enlarged lymph nodes, prior radiation to the neck, or family history of thyroid cancer

Nodules that are very small, purely cystic, or have very-low-suspicion ultrasound features often do not require biopsy at all and can simply be monitored.

What do biopsy results mean?

FNA results are reported using the Bethesda System — a six-category classification updated in 2023 — ranging from non-diagnostic to clearly malignant 4. Most results fall into the benign category (Bethesda II), which carries a very low risk of malignancy and generally means continued surveillance rather than surgery. Indeterminate results (Bethesda categories III and IV) sometimes prompt a repeat biopsy or molecular testing to better characterize the cells before deciding on surgery 4.

How are thyroid nodules followed over time?

For nodules that are benign or low-risk on ultrasound, periodic surveillance is the standard approach. Surveillance intervals depend on the nodule's risk category 13:

  • Very-low-risk (e.g., spongiform) nodules below 1 cm may not need follow-up imaging at all
  • Low-suspicion nodules: repeat ultrasound at 12 to 24 months
  • Intermediate or high suspicion nodules below biopsy threshold: repeat at 12 months
  • Benign on FNA: follow-up ultrasound at 12 to 24 months, then at longer intervals if stable

Growth of more than 20% in two dimensions (with at least a 2 mm absolute increase) on follow-up imaging is typically a trigger for biopsy even if a previous FNA was benign 1.

Who should I see for a thyroid nodule?

Thyroid nodule evaluation is led by an endocrinologist — a physician who specializes in hormonal and metabolic conditions including thyroid disease. In some cases, a radiologist or head-and-neck surgeon is also involved depending on what the evaluation reveals. Your primary care clinician is a good starting point if the nodule was found incidentally; they can order the initial workup and refer you to the appropriate specialist.

Gale can help you understand what questions to ask before your specialist visit and how to prepare for a follow-up ultrasound or biopsy.

Common questions

Should I worry that my thyroid nodule is cancer?

The great majority of thyroid nodules are benign — fewer than 5% are malignant on biopsy. Thyroid cancer does occur, but most types grow slowly and respond very well to treatment. A structured ultrasound evaluation — and biopsy when the features warrant it — gives you a clear answer rather than prolonged uncertainty.

Do thyroid nodules cause symptoms?

Most nodules cause no symptoms at all and are found incidentally. Larger nodules may occasionally cause a feeling of fullness or pressure in the neck, difficulty swallowing, or a visible lump. A nodule that produces thyroid hormone on its own (a 'hot' or autonomous nodule) can cause symptoms of an overactive thyroid, such as heart palpitations or unintended weight loss.

Will I need surgery for my thyroid nodule?

Most people with thyroid nodules do not need surgery. Surgery is typically reserved for nodules that are cancerous on biopsy, indeterminate with features suggesting higher risk, very large and causing compressive symptoms, or functionally overactive and unresponsive to other treatment.

What specialist handles thyroid nodules?

Endocrinologists most commonly manage thyroid nodule evaluation and follow-up. Thyroid surgeons (often ENT or general surgeons with thyroid expertise) are involved when surgery is under consideration. Your primary care clinician can coordinate a referral and receive the initial ultrasound report.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Signs that warrant prompt evaluation

  • —Rapidly enlarging lump in the neck
  • —Hoarseness or voice change that does not go away
  • —Difficulty swallowing or breathing
  • —Enlarged lymph nodes in the neck alongside a thyroid nodule
  • —Prior radiation treatment to the head or neck (raises thyroid cancer risk)

This article is general health education and does not replace evaluation by a clinician. Only a clinician who has reviewed your ultrasound images and clinical history can advise you on whether biopsy or follow-up is appropriate for your specific nodule. Gale can help you navigate to the right specialist.

References

  1. 1.Haugen BR, Alexander EK, Bible KC, et al. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. doi:10.1089/thy.2015.0020 ✓Ultrasound risk stratification, FNA biopsy indications, surveillance intervals, and growth thresholds for repeat biopsy in thyroid nodule management
  2. 2.National Cancer Institute (2025). Thyroid Cancer Screening (PDQ) — Health Professional Version. NCI Cancer Information Summaries. link ✓Thyroid cancer incidence (~44,000 new US cases/year), 10-year survival >98% for papillary type, and the evidence that fewer than 5% of evaluated thyroid nodules are malignant
  3. 3.Tessler FN, Middleton WD, Grant EG, et al. (2017). ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. Journal of the American College of Radiology. doi:10.1016/j.jacr.2017.01.046 ✓Feature-based risk stratification criteria (composition, echogenicity, shape, margins, echogenic foci), biopsy size thresholds by risk level, and surveillance intervals for thyroid nodules
  4. 4.Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA (2023). The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. doi:10.1089/thy.2023.0141 ✓Six-category FNA classification system (Bethesda I–VI), malignancy risk estimates by category, and guidance for indeterminate results (categories III and IV) including molecular testing

4 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.